UM Guidelines

Medical Oncology GRG

General Recovery Guideline (GRG): PG-ONC
BCBST modification effective September 11, 2012*
Added to Clinical Indications for Allogeneic bone marrow or peripheral blood stem cell transplantation:
   
....
Myeloproliferative neoplasms
....
 

References

  1. A Cancer Journal for Clinicians. (2011, June). Advances in understanding and management of myeloproliferative neoplasms. Retrieved June 28, 2011 from http://caonline.amcancersoc.org/cgi/content/full/59/3/171.
  2. BlueCross BlueShield Association. Medical Policy Reference Manual. (11:2010). Allogeneic stem-cell transplantation for myelodysplastic syndromes and myeloproliferative neoplasms (8.01.21). Retrieved June 7, 2011 from BlueWeb.
  3. BlueCross BlueShield of Tennessee network physicians. June - September 2012.
  4. Complete Guide to Medicare Coverage Issues [Computer software]. (2012, April). Stem Cell Transplantation (NCD 110.8.1, p. 2-51). Ingenix.